U.S. trade office reviewing India’s Supreme Court drug ruling

By Doug Palmer WASHINGTON (Reuters) – The United States said on Tuesday it was considering its response to an Indian Supreme Court ruling that U.S. drug manufacturers warn is the latest sign of a “deteriorating” environment for intellectual property rights in the country. “We are … reviewing the Court’s order. We look forward to continued engagement and successful collaboration with India on these issues,” said Andrea Mead, a spokeswoman for the U.S. Trade Representative’s office. …